vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
DogSelected confirmed or strongly suspected upper-GI ulcerative/erosive disease when sucralfate has a defined mucosal-protective role
5.9/10
Weak evidence support
CatSelected confirmed or strongly suspected upper-GI ulcerative/erosive disease when sucralfate has a defined mucosal-protective role
Information not fully verifiedUse a veterinarian-selected sucralfate regimen, not the human Sucralan schedule. Existing veterinary references preserve separate alternatives: dogs 500–1000 mg (2.5–5 ml) PO q6–8h or q8–12h; cats 250–500 mg (1.25–2.5 ml) PO q8–12h, with a separate 250 mg (1.25 ml) alternative and a safety signal at 500 mg q8h in feline CKD. Knead the sachet before measuring. One sachet contains 5 ml; any fraction needs an appropriate oral syringe. Opened-partial-sachet stability and homogeneity are unverified, so do not assume the remainder can be stored.
Sucralfate: No dose supported by a publicly verifiable source yet
Known Contraindications
Critical(Cat)
In a small study of cats with chronic kidney disease and normal phosphate, three of five cats given sucralfate deteriorated (vomiting, loss of appetite, constipation, worsening azotaemia). The study was stopped because of these effects and the lack of benefit, which contradicts the usual claim that sucralfate has almost no adverse effects.
Sources: MSD Vet Manual
Warning
In renal failure, aluminium absorption from sucralfate may increase. Prolonged treatment can therefore increase the risk of aluminium toxicity and requires caution.
Sources: ACVIM · MSD Vet Manual
Warning
Contraindicated in known hypersensitivity to sucralfate or any excipient. Reported hypersensitivity reactions include dyspnoea, rash, urticaria, anaphylaxis, and bronchospasm.
Sources: FDA
Warning
No pregnancy data are available in dogs or cats. Sucralfate is minimally absorbed, making systemic exposure less likely, but this is a pharmacological inference rather than evidence of safety.
Sources: MSD Vet Manual
Warning
No lactation data are available in dogs or cats. Minimal absorption makes systemic exposure less likely, but this remains a pharmacological inference rather than evidence of safety.
Sources: Product label
Caution
Sucralfate is less effective than a proton pump inhibitor for gastrointestinal ulceration and erosion, and there is no evidence that adding it to a proton pump inhibitor or an H2 blocker brings extra benefit. If a proton pump inhibitor is already given, adding sucralfate is not justified.
Sucralfate, antacids, and mineral supplements containing iron, aluminium, calcium, magnesium, zinc, or other divalent or trivalent cations can reduce quinolone absorption and bioavailability. The magnitude is drug-specific; marbofloxacin is covered by a direct product warning.
Recommendation: Avoid concurrent oral administration. If both medicines are necessary, separate sucralfate or the cation-containing product from the quinolone by at least 2 hours and monitor clinical response.
In dogs, concurrent administration of sucralfate suspension reduced doxycycline AUC from 36.0 to 7.2 h·mcg/mL (relative bioavailability 20%). No interaction was detected with sucralfate tablets because tablet fragments were visible in faeces, indicating that the tablets did not disintegrate and were not effective.
Recommendation: Separate administration by 2 hours: give doxycycline first and sucralfate 2 hours later. With this schedule, bioavailability is 74% and is not statistically different from doxycycline alone.
The concomitant administration of substances containing magnesium or aluminium may reduce the absorption of enrofloxacin. These drugs should be administered two hours apart.
Recommendation: Separation is not critical in dogs, but a 2-hour interval is safe and label-consistent. No comparable measurement exists in cats; use a 2-hour interval in cats.
Divalent and trivalent cations, including magnesium, iron, aluminium, and calcium, can chelate oxytetracycline and reduce its absorption. Do not give it at the same time as milk or antacids.
Recommendation: Separate this medicine from oral oxytetracycline in time.
Related products
Products are connected by name, active ingredients, or therapeutic group. They are not direct substitutes for one another.
Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.
For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.
Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.
The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.
